Possible New Liver Fibrosis Therapy
By expanding the applicability of cellular array technology, learn how San Diego researchers may have found a direction for the therapeutic intervention of liver fibrosis.
Continue reading »Hepatitis C Treatments/Therapies
HCV Trial Begins for New Immune Drug
SciClone begins a Phase II trial to evaluate how a new drug designed to stimulate the immune system fares against Hepatitis C.
Continue reading »Medivir AB and Tibotec Partner Up To Develop Hepatitis C Polymerase Drug
By focusing in on HCV polymerase NS5B, two companies join forces to develop new and effective medications for inhibiting the Hepatitis C virus.
Continue reading »Asparagus Has Potential to Benefit Hepatitis C
Research out of Korea suggests that asparagus is a liver protector, a notion that could benefit Hepatitis C sufferers.
Continue reading »Blueberries: Nature's Hepatitis C Suppressant
Aug 25, 2009
1 Comment
Often regarded as the premiere anti-aging fruit, nutritionists have long known that blueberries contain potent antioxidants. Discover why new research gives those with Hepatitis C reason to fully comprehend the value of blueberries.
Continue reading »Blueberries Offer Hope for Hepatitis C
Japanese researchers have found evidence that an extract from blueberry leaves hinders Hepatitis C viral replication.
Continue reading »Hepatitis C Antibody Begins Human Testing
Possibly representing a new era in Hepatitis C treatment and prevention, MassBiologics has begun Phase I testing of a human monoclonal antibody designed to neutralize the Hepatitis C virus.
Continue reading »Acupuncture May Smooth Liver Transplant Recovery
Jul 30, 2009
1 Comment
As major surgery requiring general anesthesia, a liver transplant involves the challenging post-operative recovery period. Now researchers from Duke University have found that acupuncture is a safe and effective way to ease the transition between operating table and hospital dismissal.
Continue reading »Shorter & More Effective: Triple Drug Treatment for Hepatitis C
Phase III trials are currently underway to confirm previous study results claiming telaprevir improves Hepatitis C treatment. If this last stage of testing proves a better outcome in a shorter period of time, this medicine will become the third component of standard HCV therapy.
Continue reading »Adding Boceprevir to HCV Combination Therapy Doubles Success Rate
After four months of adding boceprevir to peginterferon alfa-2b and ribavirin, a whopping 75 percent of treatment-naïve individuals with Hepatitis C genotype 1 had undetectable viral levels.
Continue reading »
